NDT (Natural Desiccated Thyroid) vs. Synthroid: The Ongoing Debate

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

The choice between Natural Desiccated Thyroid (NDT) and synthetic levothyroxine (Synthroid, Levoxyl) for hypothyroidism treatment remains a significant point of contention among patients and practitioners. While Synthroid, a pure T4 preparation, is the standard of care, NDT, derived from porcine thyroid glands, contains a combination of T4, T3, T2, T1, and calcitonin. This fundamental difference in composition drives the ongoing debate regarding efficacy, patient preference, and physiological re

Synthroid (Levothyroxine): The Standard of Care

Synthroid is a synthetic form of T4, the prohormone produced by the thyroid gland. It is the most widely prescribed thyroid medication globally, and its use is supported by decades of research and clinical experience. The advantages of Synthroid include:

Purity and Consistency: As a synthetic hormone, levothyroxine offers precise dosing and consistent potency, minimizing batch-to-batch variability.
Long Half-Life: T4 has a half-life of approximately 7 days, allowing for once-daily dosing and stable serum levels.
Physiological Conversion: The body's peripheral tissues convert T4 to the active T3 as needed, theoretically mimicking natural thyroid function.
Extensive Safety Data: Levothyroxine has a well-established safety profile and is effective in normalizing TSH and resolving hypothyroid symptoms in a majority of patients [1].

NDT (Natural Desiccated Thyroid): A Holistic Approach

NDT, such as Armour Thyroid or Nature-Throid, is derived from the dried thyroid glands of pigs. It contains a full spectrum of thyroid hormones (T4, T3, T2, T1) and calcitonin, in ratios similar to those found in the human thyroid gland. Proponents of NDT argue that this "bio-identical" approach offers a more complete hormone replacement, particularly for patients who do not thrive on T4 monotherapy.

Arguments for NDT include:

T4 and T3 Combination: NDT provides both T4 and T3, which can be beneficial for individuals with impaired T4 to T3 conversion or those who feel better with direct T3 supplementation. The T4:T3 ratio in NDT is approximately 4:1, whereas the human thyroid typically secretes T4 and T3 in a ratio of about 14:1 [2].
Presence of Other Hormones: The inclusion of T1, T2, and calcitonin is believed by some to offer additional physiological benefits, although the clinical significance of these minor hormones is not fully established.
Patient Preference: A significant number of patients report feeling better on NDT, experiencing improvements in energy, mood, weight, and cognitive function, even when their TSH is normalized on Synthroid [3].

The Ongoing Debate and Clinical Evidence

The debate between NDT and Synthroid largely stems from the observation that a substantial minority of patients remain symptomatic on T4 monotherapy despite achieving target TSH levels. While some studies have shown no significant difference in primary outcomes between NDT and levothyroxine, others have indicated a patient preference for NDT.

A randomized, double-blind, crossover study published in the Journal of Clinical Endocrinology & Metabolism found that 49% of patients preferred NDT, 19% preferred levothyroxine, and 32% had no preference. Patients on NDT also reported improved mood and weight loss, despite no significant differences in thyroid function tests (TSH, Free T4, Free T3) between the two treatments [4]. This suggests that subjective well-being can be a critical factor not always captured by standard lab metrics.

Dosing and Monitoring Considerations

Switching between NDT and Synthroid requires careful titration and monitoring. For NDT, dosing is typically initiated at a low dose (e.g., 30 mg daily) and gradually increased based on clinical symptoms and lab values. Due to the T3 content, NDT can cause transient hyperthyroid symptoms if increased too rapidly. Monitoring should include TSH, Free T4, and Free T3, with the goal of symptom resolution and optimal free hormone levels, rather than strict TSH normalization alone.

For Synthroid, the starting dose is usually 25-50 mcg daily, titrated to achieve a TSH between 0.5-2.5 mIU/L. Monitoring primarily focuses on TSH and Free T4.

Individualized Treatment is Key

Ultimately, the "best" thyroid medication is the one that effectively resolves a patient's symptoms and optimizes their well-being with minimal side effects. For many, Synthroid is perfectly adequate. However, for those who continue to struggle, NDT or combination T4/T3 therapy represents a valid alternative that should be considered under the guidance of a knowledgeable practitioner. The decision should be individualized, taking into account patient symptoms, preferences, and comprehensive lab evaluations.

References

[1] Biondi, B., & Cooper, D. S. (2008). Benefits of thyroxine replacement therapy in subclinical hypothyroidism: a literature review. Journal of Clinical Endocrinology & Metabolism, 93(5), 1772-1779. https://doi.org/10.1210/jc.2007-2409

[2] Hoang, T. D., et al. (2013). Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. Journal of Clinical Endocrinology & Metabolism, 98(5), 1982-1990. https://doi.org/10.1210/jc.2012-3480

[3] Cooper, D. S. (2009). Thyroid hormone replacement therapy in hypothyroidism. Endocrinology and Metabolism Clinics of North America, 38(2), 333-345. https://doi.org/10.1016/j.ecl.2009.01.003

[4] Hoang, T. D., et al. (2013). Desiccated thyroid extract compared with levothyroxine in the treatment of hypothyroidism: a randomized, double-blind, crossover study. Journal of Clinical Endocrinology & Metabolism, 98(5), 1982-1990. https://doi.org/10.1210/jc.2012-3480